制药行业与CSIR-CDRI研究合作的机遇

Q4 Pharmacology, Toxicology and Pharmaceutics

INDIAN DRUGS Pub Date : 2023-07-03 DOI:10.53879/id.60.06.p0005

{"title":"制药行业与CSIR-CDRI研究合作的机遇","authors":"","doi":"10.53879/id.60.06.p0005","DOIUrl":null,"url":null,"abstract":"Dear Reader, Industry can look forward to work with CSIR-CDRI in this new era of dynamic leadership of CSIR, with Dr. (Mrs) N. Kalaiselvi, the new Director General of CSIR and Secretary, DSIR and Dr. (Mrs) Radha Rangarajan, Director, CDRI, Lucknow, who has recently taken charge of this pioneer pharmaceutical research laboratory in India which has a very distinguished track record in drug discovery research from early days, especially from the times of Dr. Nitya Anand, Director of CSIR-CDRI from 1974 to 1984","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"OPPORTUNITIES FOR PHARMA INDUSTRY’S RESEARCH COLLABORATIONS WITH CSIR-CDRI\",\"authors\":\"\",\"doi\":\"10.53879/id.60.06.p0005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dear Reader, Industry can look forward to work with CSIR-CDRI in this new era of dynamic leadership of CSIR, with Dr. (Mrs) N. Kalaiselvi, the new Director General of CSIR and Secretary, DSIR and Dr. (Mrs) Radha Rangarajan, Director, CDRI, Lucknow, who has recently taken charge of this pioneer pharmaceutical research laboratory in India which has a very distinguished track record in drug discovery research from early days, especially from the times of Dr. Nitya Anand, Director of CSIR-CDRI from 1974 to 1984\",\"PeriodicalId\":13409,\"journal\":{\"name\":\"INDIAN DRUGS\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"INDIAN DRUGS\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53879/id.60.06.p0005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"INDIAN DRUGS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53879/id.60.06.p0005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}

引用次数: 0

摘要

亲爱的读者，业界期待着在CSIR充满活力的领导新时代与CSIR-CDRI合作，与CSIR新任总干事兼DSIR秘书N.Kalaiselvi博士（夫人）和勒克瑙CDRI董事Radha Rangarajan博士（女士）合作，他最近负责印度这家先驱药物研究实验室，该实验室从早期开始就在药物发现研究方面有着杰出的记录，尤其是从1974年至1984年担任CSIR-CDRI主任的Nitya Anand博士开始

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

OPPORTUNITIES FOR PHARMA INDUSTRY’S RESEARCH COLLABORATIONS WITH CSIR-CDRI

Dear Reader, Industry can look forward to work with CSIR-CDRI in this new era of dynamic leadership of CSIR, with Dr. (Mrs) N. Kalaiselvi, the new Director General of CSIR and Secretary, DSIR and Dr. (Mrs) Radha Rangarajan, Director, CDRI, Lucknow, who has recently taken charge of this pioneer pharmaceutical research laboratory in India which has a very distinguished track record in drug discovery research from early days, especially from the times of Dr. Nitya Anand, Director of CSIR-CDRI from 1974 to 1984

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

INDIAN DRUGS Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science

CiteScore

0.30

自引率

0.00%

发文量